Uscom Ltd (Uscom) is a medical device company that focuses on the development, design, manufacture and marketing of non-invasive cardiovascular and pulmonary monitoring technologies. Its product portfolio includes its flagship product USCOM 1A (ultrasonic cardiac output monitor) non-invasive, beat to beat, real time cardiac output monitor based on continuous wave Doppler ultrasound; BP+, a non-invasive automatic blood pressure monitoring device based on supra systolic oscillometric central blood pressure technology and Spirosonic, an ultrasonic spirometer for pulmonary function testing. The company operates in China, Europe and the US. It markets products worldwide through distributors and partnerships. Uscom is headquartered in Sydney, Australia.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Uscom Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Uscom Ltd Company Overview
- Uscom Ltd Company Snapshot
- Uscom Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Uscom Ltd - Pipeline Analysis Overview
- Business Description
- Uscom Ltd - Key Facts
- Uscom Ltd - Major Products and Services
- Uscom Ltd Pipeline Products by Development Stage
- Uscom Ltd Ongoing Clinical Trials by Trial Status
- Uscom Ltd Pipeline Products Overview
- SpiroReader
- SpiroReader Product Overview
- SpiroReporter
- SpiroReporter Product Overview
- SpiroSonic AIR
- SpiroSonic AIR Product Overview
- SpiroSonic Flo
- SpiroSonic Flo Product Overview
- SpiroSonic HD
- SpiroSonic HD Product Overview
- SpiroSonic Mobile
- SpiroSonic Mobile Product Overview
- SpiroSonic Smart
- SpiroSonic Smart Product Overview
- Spirosonic SmartSpacer
- Spirosonic SmartSpacer Product Overview
- Spirosonic Whistler
- Spirosonic Whistler Product Overview
- Spirosonic WiFi
- Spirosonic WiFi Product Overview
- USCOM Basic
- USCOM Basic Product Overview
- Uscom BP+
- Uscom BP+ Product Overview
- Uscom BP+ Clinical Trial
- Uscom BP+ Reporter
- Uscom BP+ Reporter Product Overview
- USCOM O2
- USCOM O2 Product Overview
- Uscom Ltd - Key Competitors
- Uscom Ltd - Key Employees
- Uscom Ltd - Key Employee Biographies
- Uscom Ltd - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Uscom Ltd, Recent Developments
- Jul 21, 2022: China NMPA accepts registration for SpiroSonic spirometers
- Apr 28, 2022: AIR FDA 510K filed and new US Distribution
- Nov 08, 2021: Ten-year China patents issued for USCOM 1A
- Nov 03, 2021: Uscom and US Koneksa extend technology partnership
- Sep 23, 2021: Uscom announced BP+ 94% effective for AF screening in primary care
- Aug 11, 2021: Uscom : Five new software copyrights for BP+ in China
- Jul 07, 2021: Russian regulatory approval and distribution for USCOM 1A
- Jul 07, 2021: Amended: Russian regulatory approval and distribution for USCOM 1A
- May 27, 2021: Two new USCOM monitors get Australian TGA clearance
- May 24, 2021: SpiroSonic AIR approved for European CE mark
- Appendix
- Methodology
- About the Publisher
- Contact Us
- Disclaimer
- Uscom Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Uscom Ltd Pipeline Products by Equipment Type
- Uscom Ltd Pipeline Products by Indication
- Uscom Ltd Ongoing Clinical Trials by Trial Status
- Uscom Ltd, Key Facts
- Uscom Ltd, Major Products and Services
- Uscom Ltd Number of Pipeline Products by Development Stage
- Uscom Ltd Pipeline Products Summary by Development Stage
- Uscom Ltd Ongoing Clinical Trials by Trial Status
- Uscom Ltd Ongoing Clinical Trials Summary
- SpiroReader - Product Status
- SpiroReader - Product Description
- SpiroReporter - Product Status
- SpiroReporter - Product Description
- SpiroSonic AIR - Product Status
- SpiroSonic AIR - Product Description
- SpiroSonic Flo - Product Status
- SpiroSonic Flo - Product Description
- SpiroSonic HD - Product Status
- SpiroSonic HD - Product Description
- SpiroSonic Mobile - Product Status
- SpiroSonic Mobile - Product Description
- SpiroSonic Smart - Product Status
- SpiroSonic Smart - Product Description
- Spirosonic SmartSpacer - Product Status
- Spirosonic SmartSpacer - Product Description
- Spirosonic Whistler - Product Status
- Spirosonic Whistler - Product Description
- Spirosonic WiFi - Product Status
- Spirosonic WiFi - Product Description
- USCOM Basic - Product Status
- USCOM Basic - Product Description
- Uscom BP+ - Product Status
- Uscom BP+ - Product Description
- Uscom BP+ - Concordance Between Central Blood PRessure dEvices In Nephrology Patients (CBP-REIN)
- Uscom BP+ Reporter - Product Status
- Uscom BP+ Reporter - Product Description
- USCOM O2 - Product Status
- USCOM O2 - Product Description
- Uscom Ltd, Key Employees
- Uscom Ltd, Key Employee Biographies
- Uscom Ltd, Other Locations
- Uscom Ltd, Subsidiaries
- Glossary
- Uscom Ltd Pipeline Products by Equipment Type
- Uscom Ltd Pipeline Products by Development Stage
- Uscom Ltd Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Device Technologies Australia Pty Ltd
- Respiri Ltd
- CardieX Ltd
- Anteris Technologies Ltd
- Nihon Kohden Corp
